J A Sutherland - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

J A Sutherland

Showing results (21-30 of 21) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 21 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009

Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of responseNan Soon Wong, Robert A Buckman, Mark Clemons, et al.

Pageof 3

Search research articles

Showing results (21-30 of 21) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 21 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 23, 2009

Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial growth factor receptor levels as markers of responseNan Soon Wong, Robert A Buckman, Mark Clemons, et al.

Pageof 3